CLINICAL_TRIALS
trial_result
· 2022-01-27
Clinical Trial Update: Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy [Phase 2]
Summary
Phase 2 dose-finding trial update for grass pollen allergy showing results in rhinitis and rhinoconjunctivitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Inmunotek S.L. | Conditions: Rhinitis, Rhinoconjunctivitis | Phase 2 | Status: COMPLETED